Vice presidential nominee JD Vance recently stated in interviews that a Trump administration would not use the FDA to block access to the abortion drug mifepristone. Vance emphasized that individual states should have the authority to make decisions regarding abortion policy.
Vance clarified that if reelected, former President Donald Trump would not interfere with access to the drug. However, Vance indicated that Trump's approach would involve allowing states to determine their own abortion policies. This stance could result in a varied landscape of regulations, with some states having fewer restrictions (blue states) and others imposing more stringent rules (red states).
During one interview, Vance was reminded that the Supreme Court only addressed the FDA's regulation of mifepristone after the overturning of Roe v. Wade. In a subsequent ruling, the Court determined that the parties challenging the FDA's approach lacked standing to sue.
Vance emphasized the importance of respecting decisions made by states and their voters on abortion issues. He advocated for a shift away from the cultural aspects of the abortion debate and towards a model where states have autonomy in setting their specific abortion policies.
It was highlighted that Vance, in his capacity as a senator, had signed a letter urging the Justice Department to halt all mail-order abortion operations under the Comstock Act. Vance defended this action by stating that the primary concern was ensuring that doctors prescribed the drug safely. He reiterated that the goal was to empower states to make determinations on abortion policies.
